Publicaciones en las que colabora con LUIS CARREÑO PÉREZ (77)

2020

  1. Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study

    Arthritis Care and Research, Vol. 72, Núm. 6, pp. 822-828

2017

  1. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, singleblind, placebo-controlled phase Ib/IIa clinical trial

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 196-202

  2. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

2016

  1. Multiobserver reliability of ultrasound assessment of salivary glands in patients with established primary sjögren syndrome

    Journal of Rheumatology, Vol. 43, Núm. 10, pp. 1858-1863

  2. Structural damage in rheumatoid arthritis: Comparison between tendon damage evaluated by ultrasound and radiographic damage

    Rheumatology (United Kingdom), Vol. 55, Núm. 6, pp. 1042-1046

  3. The feet in systemic lupus erythematosus; are we underestimating their involvement and functional impact?

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 4, pp. 609-617

  4. Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?

    Rheumatology International, Vol. 36, Núm. 3, pp. 387-396

2015

  1. Comparison between full and tapered dosages of biologic therapies in psoriatic arthritis patients: clinical and ultrasound assessment

    Clinical Rheumatology, Vol. 34, Núm. 5, pp. 935-942

  2. Comparison of two ELISA versions for infliximab serum levels in patients diagnosed with ankylosing spondylitis

    Rheumatology International, Vol. 35, Núm. 6, pp. 1021-1025

  3. Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]

    Seminars in Arthritis and Rheumatism

  4. Impact of musculoskeletal ultrasound on clinical practice in paediatric rheumatology

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 4, pp. 583-587

  5. Investigating the link between disease activity and infliximab serum levels in rheumatoid arthritis patients

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 6, pp. 805-811

  6. Juvenile, adult and late-onset systemic lupus erythematosus: A long-term follow-up study from a geographic and ethnically homogeneous population

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 6, pp. 788-794

  7. Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis

    Rheumatology (United Kingdom), Vol. 54, Núm. 8, pp. 1408-1414

2014

  1. Does ultrasound-scored synovitis depend on the pharmacokinetics of subcutaneous anti-TNF agents in patients with rheumatoid arthritis?

    Rheumatology (United Kingdom), Vol. 53, Núm. 11, pp. 2088-2094

  2. Minimum Effective Dosages of Anti-TNF in Rheumatoid Arthritis: A Cross-sectional Study

    Reumatologia Clinica, Vol. 10, Núm. 2, pp. 101-104

  3. Salivary gland ultrasound in children: A useful tool in the diagnosis of juvenile Sjögren's syndrome

    Clinical and Experimental Rheumatology, Vol. 32, Núm. 4, pp. 578-580

  4. The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: Results from a nationwide cohort in Spain (LESIMAB)

    Lupus, Vol. 23, Núm. 10, pp. 1014-1022

2013

  1. Anti-TNF treatments in rheumatoid arthritis: Economic impact of dosage modification

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Núm. 3, pp. 407-414

  2. Idiopathic recurrent pericarditis treated successfully with tumour necrosis factor alpha blocking agents (anti-TNF-α)

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 5, pp. 776-778